Advocate

Country: European Union

Language: Latvian

Source: EMA (European Medicines Agency)

Active ingredient:

imidakloprīdu, moksidektīns

Available from:

Bayer Animal Health GmbH

ATC code:

QP54AB52

INN (International Name):

imidacloprid, moxidectin

Therapeutic group:

Dogs; Cats; Ferrets

Therapeutic area:

Antiparazītu līdzekļi, insekticīdi un repelentu līdzekļi

Therapeutic indications:

DogsFor suņiem, kas cieš no tā, vai risks, sajauc parazitāras infekcijas:to ārstēšanu un profilaksi blusu invāzijas (Ctenocephalides felis),attieksme pret nokošana utis (Trichodectes canis),ārstēšana, ausu ērces invāzijas (Otodectes cynotis), sarcoptic kašķis (ko izraisa Sarcoptes scabiei var. canis), demodicosis (ko izraisa Demodex canis),profilakses heartworm slimības (L3 un L4 kāpuru par Dirofilaria immitis),ārstēšanas cirkulācijas microfilariae (Dirofilaria immitis),ārstēšanu, ādas dirofilariosis (pieaugušo posmos Dirofilaria repens)lai novērstu ādas dirofilariosis (L3 kāpuriem par Dirofilaria repens),samazinot apritē microfilariae (Dirofilaria repens),novēršanu angiostrongylosis (L4 kāpuru un mazuļu vidū Angiostrongylus vasorum),attieksme pret Angiostrongylus vasorum un Crenosoma vulpis,profilakse spirocercosis (Spirocerca lupi),attieksme pret Eucoleus (syn. Capillaria) boehmi (pieaugušajiem),attieksme pret aci tārps Thelazia callipaeda (pieaugušajiem),infekciju ārstēšanai ar kuņģa-zarnu trakta nematodes (L4 kāpuru, mazuļu pieaugušajiem un pieaugušajiem par Toxocara canis, Ancylostoma caninum un Uncinaria stenocephala, pieaugušajiem, Toxascaris leonina un Trichuris vulpis). Produktu var izmantot kā daļu no blusu alerģiskā dermatīta (FAD) terapijas stratēģijas.. CatsFor kaķiem, kas cieš no tā, vai risks, sajauc parazitāras infekcijas:to ārstēšanu un profilaksi blusu invāzijas (Ctenocephalides felis),ārstēšana, ausu ērces invāzijas (Otodectes cynotis),attieksme pret notoedric kašķis (Notoedres cat),apstrādes lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (pieaugušie),novēršanu lungworm slimības (L3/L4 kūniņas Aelurostrongylus abstrusus),apstrādes lungworm Aelurostrongylus abstrusus (pieaugušajiem),attieksme pret aci tārps Thelazia callipaeda (pieaugušajiem),profilakses heartworm slimības (L3 un L4 kāpuru par Dirofilaria immitis),infekciju ārstēšanai ar kuņģa-zarnu trakta nematodes (L4 kāpuru, mazuļu pieaugušajiem un pieaugušajiem par Toxocara cat un Ancylostoma tubaeforme). Produktu var izmantot kā daļu no blusu alerģiskā dermatīta (FAD) terapijas stratēģijas.. FerretsFor mājas seski cieš no tā, vai risks, sajauc parazitāras infekcijas:to ārstēšanu un profilaksi blusu invāzijas (Ctenocephalides felis),profilakses heartworm slimības (L3 un L4 kāpuru par Dirofilaria immitis).

Product summary:

Revision: 23

Authorization status:

Autorizēts

Authorization date:

2003-04-02

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Jaunākā informācija par šīm veterinārajām zālēm ir pieejama
Veterināro zāļu informācijas tīmekļa
vietnē.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Jaunākā informācija par šīm veterinārajām zālēm ir pieejama
Veterināro zāļu informācijas tīmekļa
vietnē.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 31-01-2024
Public Assessment Report Public Assessment Report Bulgarian 29-01-2024
Patient Information leaflet Patient Information leaflet Spanish 31-01-2024
Public Assessment Report Public Assessment Report Spanish 29-01-2024
Patient Information leaflet Patient Information leaflet Czech 31-01-2024
Public Assessment Report Public Assessment Report Czech 29-01-2024
Patient Information leaflet Patient Information leaflet Danish 31-01-2024
Public Assessment Report Public Assessment Report Danish 29-01-2024
Patient Information leaflet Patient Information leaflet German 31-01-2024
Public Assessment Report Public Assessment Report German 29-01-2024
Patient Information leaflet Patient Information leaflet Estonian 31-01-2024
Public Assessment Report Public Assessment Report Estonian 29-01-2024
Patient Information leaflet Patient Information leaflet Greek 31-01-2024
Public Assessment Report Public Assessment Report Greek 29-01-2024
Patient Information leaflet Patient Information leaflet English 31-01-2024
Public Assessment Report Public Assessment Report English 29-01-2024
Patient Information leaflet Patient Information leaflet French 31-01-2024
Public Assessment Report Public Assessment Report French 29-01-2024
Patient Information leaflet Patient Information leaflet Italian 31-01-2024
Public Assessment Report Public Assessment Report Italian 29-01-2024
Patient Information leaflet Patient Information leaflet Lithuanian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 31-01-2024
Public Assessment Report Public Assessment Report Lithuanian 29-01-2024
Patient Information leaflet Patient Information leaflet Hungarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 31-01-2024
Public Assessment Report Public Assessment Report Hungarian 29-01-2024
Patient Information leaflet Patient Information leaflet Maltese 31-01-2024
Public Assessment Report Public Assessment Report Maltese 29-01-2024
Patient Information leaflet Patient Information leaflet Dutch 31-01-2024
Public Assessment Report Public Assessment Report Dutch 29-01-2024
Patient Information leaflet Patient Information leaflet Polish 31-01-2024
Public Assessment Report Public Assessment Report Polish 29-01-2024
Patient Information leaflet Patient Information leaflet Portuguese 31-01-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 31-01-2024
Public Assessment Report Public Assessment Report Portuguese 29-01-2024
Patient Information leaflet Patient Information leaflet Romanian 31-01-2024
Public Assessment Report Public Assessment Report Romanian 29-01-2024
Patient Information leaflet Patient Information leaflet Slovak 31-01-2024
Public Assessment Report Public Assessment Report Slovak 29-01-2024
Patient Information leaflet Patient Information leaflet Slovenian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 31-01-2024
Public Assessment Report Public Assessment Report Slovenian 29-01-2024
Patient Information leaflet Patient Information leaflet Finnish 31-01-2024
Public Assessment Report Public Assessment Report Finnish 29-01-2024
Patient Information leaflet Patient Information leaflet Swedish 31-01-2024
Public Assessment Report Public Assessment Report Swedish 29-01-2024
Patient Information leaflet Patient Information leaflet Norwegian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 31-01-2024
Public Assessment Report Public Assessment Report Norwegian 29-01-2024
Patient Information leaflet Patient Information leaflet Icelandic 31-01-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 31-01-2024
Public Assessment Report Public Assessment Report Icelandic 29-01-2024
Patient Information leaflet Patient Information leaflet Croatian 31-01-2024
Public Assessment Report Public Assessment Report Croatian 29-01-2024

View documents history